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4IMO Position Paper - Addiction and Dependency
Addiction and dependency remains one the most challenging public health policy issues of recent times. Since 
the 1960s, the consumption of illegal drugs and alcohol has increased to a point where over one-quarter of all 
Irish adults now state that they have used an illegal psychoactive substance recreationally, and more than half 
of all Irish adults are classified by World Health Organisation (WHO) criteria as harmful drinkers.1 In addition, 
gambling addiction has received greater attention in recent years, as the ubiquity of internet access provides 
problem gamblers with an ever-present means of exacerbating their disorder. With illegal substance and alcohol 
usage high in Ireland, comparable to other EU states, Irish public policy, health services, social services, policing, 
and legislation, must all combine in a manner that attacks the issue of harmful use and dependency on a variety 
of fronts. Without reform across these areas that places the needs of those engaging in harmful use first, from 
both preventative and curative perspectives, the burden such harmful use places on sufferers and their families, as 
well as public services and society at large, will continue. IMO doctors are advocating for sensible and workable 
measures that should be examined by legislators and policy-makers that will loosen the grip that substance abuse 
and addiction has placed on large tracts of our society.
Alcohol Dependence in Ireland
Per capita, Ireland’s alcohol consumption remains one of the highest amongst the world’s developed states. In 
2012 Ireland’s annual alcohol consumption was measured at 11.6 litres of pure alcohol per person, ranking fourth 
amongst the OECD member states.2 This figure is all the more troubling when it is considered that approximately 
21% of all Irish adults report abstaining from alcohol entirely, which is a significantly higher number than in many 
other west European countries, and indicates that the average consumption of alcohol per adult who drinks is 
a deal greater than the 11.6 litres average for all adults.3 Ireland also has a high level of alcohol dependence, 
compared to other west European states. The WHO’s assessment of the prevalence of alcohol dependence 
in Europe measures Ireland at 3.8% of the adult population.4 This places Ireland at the upper end of the west 
European scale, alongside other high consumers of alcohol such as Finland, Norway, and Sweden.
Figure 1: Percentage of Population with Alcohol Dependence - Western Europe
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Source: WHO, Global Status Report on Alcohol and Health 2014, Geneva, 2014, pp. 197-240.
1 National Advisory Committee on Drugs and Public Health Information and Research Branch, Drug use in Ireland and Northern 
Ireland: First results from the 2010/11 Drug Prevalence Survey, Dublin, 2011, p. 13; J. Long and D. Mongan, Alcohol Consumption 
in Ireland 2013: Analysis of a National Alcohol Diary Survey, Health Research Board, Dublin, 2014, p. 13.
2 Organisation for Economic Co-operation and Development (2014), OECD Health Statistics 2014: How does Ireland compare?, 
OECD Health Statistics (database), (available at http://www.oecd.org/health/healthdata [accessed on 19 February at 11.13am]).
3 J. Long and D. Mongan, Alcohol Consumption in Ireland 2013: Analysis of a National Alcohol Diary Survey, Health Research 
Board, Dublin, 2014, p. 25; World Health Organisation, European Status Report on Alcohol and Health 2010, Copenhagen, 2010, 
p. 21
4 World Health Organisation, Global Status Report on Alcohol and Health 2014, Geneva, 2014, p. 216.
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Recent research from the Health Research Board, using the American Psychiatric Association’s DSM-IV criteria, 
suggests the number of Irish adults dependent on alcohol may be far higher than reported by the United Nations 
body. In a 2013 national survey, the Health Research Board measured the prevalence of alcohol dependence 
amongst adults in Ireland at 6.9%, a figure over 80% higher than the WHO’s estimate.5 
Figure 2 contains an overview of alcohol dependence within various demographics of Irish society. Of particular note 
is the level of dependency within the eighteen to twenty-four and twenty-five to thirty-four age brackets, which are 
substantially above both the national average and the averages of all other demographics. Given the established 
correlations between alcohol abuse, psychiatric illness, and suicidality amongst younger age groups, the scale of 
this issue must be viewed as a cause of immediate and grave concern to all those with an interest in maintaining 
public health in Ireland.
Figure 2: Alcohol Dependence amongst Irish Adults
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Source: J. Long and D. Mongan, Alcohol Consumption in Ireland 2013: Analysis of a National Alcohol Diary Survey, 
Health Research Board, Dublin, 2013, p. 44.
While 6.9% of the adult population may be classified as clinically alcohol dependent, comparatively few drinkers 
are of the opinion that their drinking is particularly heavy. In fact, just 2.1% of Irish adults consider themselves to be 
heavy drinkers, with 39.6% and 58.3% describing themselves moderate and light drinkers respectively.6 The disparity 
between the percentage of the population classified as alcohol dependent and that of the cohort that defines itself 
as heavy drinkers strongly suggests that the overwhelming majority of those living with alcohol dependence do not 
believe themselves to have a clinically significant problem with the substance.
5 J. Long and D. Mongan, Alcohol Consumption in Ireland 2013: Analysis of a National Alcohol Diary Survey, Health Research Board, 
Dublin, 2014, p. 13.
6 Ibid, p. 49.
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Physical and Psychological Effects of Alcohol Dependence
Alcohol dependence is associated with a range of physical and psychological conditions. There is a strong 
correlation between the risk of liver cirrhosis and the daily volume of alcohol consumed, with approximately 
20% of people dependent on alcohol developing the disease. Chronic alcohol consumption is a significant risk 
factor for a number of cancers including cancer of the oropharynx, larynx, and oesophagus, cancer of the liver, 
colorectum, and breast, as well as a causal factor in both haemorrhagic and ischemic stroke. Alcohol dependence 
is also associated with neuropsychiatric disorders, including depression, peripheral neuropathy, and cognitive 
impairment.7
Alcohol was responsible for 799 deaths, or the equivalent of at least sixty-seven deaths every month, in Ireland in 
2008 in alcohol dependent people.8 The overwhelming majority of these deaths occurred before the age of sixty-
nine, with mortality highest in the fifty to sixty-four age bracket.9 
Supply and Prevention
In February 2012, the Department of Health published the Steering Group Report on a National Substance 
Misuse Strategy to tackle the issue of alcohol misuse. The Report makes a number of recommendations under the 
pillars of Supply, Prevention, Treatment and Rehabilitation, and Research and is aligned with the National Drugs 
Strategy 2009-2016. Recommendations under the Supply pillar include the introduction of Minimum Unit Pricing, 
restrictions on advertising and promotion of alcohol, alcohol labelling, structural separation of alcohol from 
other products in retail outlets, and the introduction of a levy on alcohol manufacturers in order to contribute to 
the healthcare costs of alcohol-related harm, all of which are supported by the IMO (see IMO Position Paper on 
Alcohol and Young People, 2013).
In October 2013 the Government announced measures to deal with alcohol misuse to be provided for in a Public 
Health (Alcohol) Bill. The Bill has yet to be drafted, but an outline of the provisions in the Bill has been provided. 
While the IMO has welcomed the proposal to introduce Minimum Unit Pricing, the organisation is disappointed 
that the Bill will not include a ban on alcohol sponsorship and promotion of sports. 
IMO Recommendation
• Implement the National Alcohol Strategy without delay, to take immediate action to ban sponsorship 
and promotion of sports by the alcohol industry, and to introduce Minimum Unit Pricing for alcohol 
products.
Drug Use and Dependency in Ireland
Drug use in Ireland has continued to increase by significant degrees over the past decade. Recently released 
statistics, compiled by the National Advisory Committee on Drugs and Alcohol (NACDA), show that the usage 
of almost all kinds of illicit drugs has increased during the last ten years. In 2003 lifetime use of any illegal drug 
stood at 18.5% of the population, but by 2011, the year of the most recent assessment, this had risen to 27.2%.10 
As is visible from Figure 3, both lifetime prevalence of drug use and usage within the last year and month, usage 
patterns which may denote regular use, have increased for almost all illegal drugs.
Usage figures in Ireland are generally high, relative to our EU counterparts, as displayed by Figure 4, which 
contrasts estimate figures for problem opioid use in Ireland, versus the average of other west European states.
7 D. Mongan, S. Reynolds, S. Fanagan, and J. Long, Health-related consequences of problem alcohol use: Overview 6, Health 
Research Board, Dublin, 2007, p. 46.
8 S. Lyons et al., Alcohol-related deaths and deaths among people who were alcohol dependent in Ireland, 2004 to 2008, Health 
Research Board, Dublin, 2011, p. 11-18.
9 Ibid.
10 National Advisory Committee on Drugs and Public Health Information and Research Branch, Drug use in Ireland and Northern 
Ireland: First results from the 2010/11 Drug Prevalence Survey, Dublin, 2011, p. 13.
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Figure 3: Drug Use Prevalence in Ireland
Lifetime use (%) Last year (%) Last month (%)
Drug 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11 2002/3 2006/7 2010/11
Any illegal drug 18.5 24.0 27.2 5.6 7.2 7.0 3.0 2.9 3.2
Cannabis 17.3 21.9 25.3 5.1 6.3 6.0 2.6 2.6 2.8
Heroin 0.5 0.4 0.8 0.1 0.1 0.1 0.1 0.0 0.1
Methadone 0.3 0.4 0.5 0.2 0.2 0.2 0.1 0.1 0.2
Other opiates ^ 3.0 6.2 38.8 0.5 2.2 27.9 0.2 0.9 14.2
Cocaine (including 
crack)
3.0 5.3 6.8 1.1 1.7 1.5 0.4 0.5 0.5
Crack 0.3 0.6 0.6 0.1 0.1 0.1 0.0 0.0 0.0
Cocaine powder 2.9 5.1 6.7 1.1 1.6 1.5 0.4 0.5 0.5
Amphetamines 2.9 3.5 4.5 0.4 0.4 0.4 0.2 0.1 0.1
Ecstasy 3.7 5.5 6.9 1.1 1.2 0.5 0.3 0.3 0.1
LSD 2.9 2.9 4.4 0.1 0.1 0.3 0.0 0.0 0.0
Magic mushrooms 3.8 5.9 6.5 0.4 0.6 0.5 0.0 0.0 0.0
Solvents 1.7 1.9 2.6 0.1 0.0 0.1 0.0 0.0 0.1
Poppers 2.6 3.3 3.9 0.4 0.5 0.2 0.1 0.1 0.1
Sedatives or 
tranquilisers
** 10.6 13.9 ** 4.7 6.5 ** 3.0 2.8
Anti-depressants ** 9.3 10.4 ** 4.4 4.8 ** 3.2 4.1
New psychoactive 
substances
*** *** *** *** *** 3.5 *** *** ***
Tobacco 60.0 57.9 56.7 38.0 36.3 32.5 33.2 32.6 28.3
Alcohol 90.1 90.2 90.3 83.3 84.0 85.3 73.9 73.2 70.6
*Any illegal drugs refers to amphetamines, cannabis, cocaine powder, crack, ecstasy, heroin, LSD, magic mushrooms, poppers and solvents.
**In 2002/3 the survey asked about use of sedatives, tranquillisers or anti-depressants together. Since 2006/7 the survey has asked about 
sedatives/tranquillisers and anti-depressants separately.
***In 2010/11 the survey asked respondents about their use of New Psychoactive Substances for the first time. The survey asked about use in 
the last 12 months only.
^ Tests for statistical significance between the prevalence of ‘Other opiates’ are not reported. As a result of measurement changes in 2006/7 
and 2010/11, the ‘Other opiates’ category is not comparable between the surveys. The measurement of ‘Other opiates’ in Ireland in 2002/3 
included nine drugs: Opium, Temgesic®, Diconal®, Napps, MSTs®, Pethidine, DF118®, (Dihydrocodeine), Buprenorphine and Morphine. 
In 2006/7 the category ‘Other opiates’ was extended to be consistent with Northern Ireland and included: Codeine, Feminax, Kapake, Diffs, 
Dikes, Peach, Fentanyl (Durogesic®, Sublimaze®, Actiq®), Oxycodone (Oxycontin®, Oxynorm®), and Buprehnorphine (Subutex®). In 2010/11 
the category ‘Other opiates’ also asked specifically about substances containing codeine such as Maxilief, Migraleve, Nurofen Plus, Codeine 
Phosp, Panadeine, Paracetamol/Caffeine/Codeine and Doxylamine, Paracodin, Paramol, Solpadeine, Solpadol, Syndol, Tylex, Uniflu Plus, 
Veganin Plus.        
Source: National Advisory Committee on Drugs and Public Health Information and Research Branch, Drug use in 
Ireland and Northern Ireland: First results from the 2010/11 Drug Prevalence Survey, Dublin, 2011, p. 13.
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Figure 4: Prevalence of Problem Opioid Use
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Sources: European Monitoring Centre for Drugs and Drug Addiction, European Drug Report 2014: Trends and 
Developments, Luxembourg, 2014, p. 73; and J. Long and S. Lyons, ‘Problem opiate use in Ireland’, Drugnet 
Ireland, Issue 32, Winter 2009, pp. 11-14.
Physical and Psychological Effects of Drug Dependency
Unlike alcoholic beverages, where a single psychoactive substance, ethanol, is responsible for the psychiatric and 
physiological side effects of consumption, a wide array of substances fall under the broad banner of illict drugs, 
all of which produce a variety of different reactions by the body, and in particular the brain.
Regardless of the various chemical effects of the array of different drug classes during intoxication, persistent use 
of virtually all drugs can produce a usage disorder within an individual. This disorder can be characterised by:
• the use of the substance in larger amounts or over a longer period than was intended;
• a persistent desire or unsuccessful efforts to cut down or control use of the substance;
• spending a lot of time on activities necessary to obtain the substance, use the substance, or recover from its 
effects;
• craving, or a strong desire or urge to use the substance;
• recurrent use of the substance resulting in a failure to fulfil major role obligations at work, school, or home;
• continued use of the substance despite having persistent or recurrent social or interpersonal problems caused 
or exacerbated by the effects of its use;
• important social, occupational, or recreational activities given up or reduced because of use of the substance; 
• recurrent use of the substance in situations in which it is physically hazardous;
• tolerance of the substance, marked by the use of increased amounts of the substance to achieve intoxication 
or desired effect, or experiencing a diminished effect while continuing to use the same amount; and
• withdrawal, manifested by exhibiting the symptoms of physical withdrawal characteristic of that substance, or 
use of the substance to alleviate or avoid withdrawal symptoms.11
The number of symptoms of substance use disorder a sufferer exhibits will, in most cases, determine the severity 
of that dependency.
11 American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders: DSM-5, American Psychiatric Association, 
Arlington, 2013.
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A large number of illegal substances see regular use in Ireland, all of which may pose serious risks to the user, 
either by presenting acutely or developing over time into chronic health problems. Broadly, the most popular of 
such chemicals can be divided into five categories, each presenting their own particular health risks. They include:
1   Sedatives and Tranquilisers
Benzodiazepines are probably the most popular class of drug within this category, with well-known names like 
Xanax and Valium being products within its class. These drugs can be legally prescribed by doctors and can be 
of benefit to patients when taken as directed over short periods of time. Long-term or unregulated use of these 
drugs can be harmful, however, as they can induce dependency, poison users when taken in large doses, and 
long-term use has been linked to neurological illnesses, like Alzheimer’s disease.12 Combining benzodiazepines 
with alcohol, or with painkillers or anti-histamines can lead to coma or respiratory failure.
2    Opiates
These are strong pain-killers and include drugs such as morphine, which is often used in hospital settings under 
the direction of a doctor. Other opiates, such as heroin, are illegal and frequently contain additives that are 
dangerous, particularly when injected. Heroin is extremely addictive and heroin users often experience a wide 
range of health problems including abscesses, blood clots, gangrene, and various intellectual and psychiatric 
disorders.13 Heroin users are also at high risk of blood-borne viruses such as Hepatitis B and C and HIV from the 
use of contaminated needles.14
3   Stimulants
Stimulants produce chemical reactions in the brain that frequently make the user feel more alert, awake, or 
energetic and include substances like amphetamines and cocaine. Their use can produce immediate negative 
health consequences, such as cardiac problems, as well as long-term psychiatric illness, such as depression and 
anxiety disorders.15 Many can also be injected, and therefore carry the risk of contracting blood-borne diseases in 
a similar manner to opioid users.
4   Hallucinogens
Hallucinogens, such as ecstasy and lysergic acid diethylamide (LSD), when ingested can produce powerful 
visions or hallucinations and addiction to this class of drugs can cause severe and lasting health problems. 
Several studies have reported that use of ecstasy (MDMA) ultimately leads to impaired memory and decreased 
performance on intelligence testing and that the level of consumption serves to increase these effects.16 There are 
suggestions that some of this brain damage can remain after use of ecstasy has long been discontinued.17
5   Cannabis
Cannabis is the most commonly used illegal drug in Ireland.18 It is generally either smoked or eaten and its use 
can therefore carry similar health risks as other forms of smoking. Cannabis is associated with memory problems 
12 S. Billioti de Gage et al., ‘Benzodiazepine use and risk of Alzheimer’s disease: case-control study‘, British Medical Journal, 
2014;349:g5205.
13 M. Lyvers and M. Yakimoff, ‘Neuropsychological correlates of opioid dependence and withdrawal’, Addictive Behaviours, Vol. 28, 
Issue 3, pp. 605-611.
14 M. Gossop et al., ‘Multiple risks for HIV and hepatitis B infection among heroin users’, Drug and Alcohol Review, Vol. 13, Issue 3, 
1994, pp. 293-300. 
15 L. L. Cregler, ‘Adverse health consequences of cocaine abuse’, Journal of the National Medical Association, Vol. 81, Issue 1, 
January 1989, pp. 27-38; B. J. Rounsaville, ‘Psychiatric Diagnoses of Treatment-Seeking Cocaine Abusers’, Archives of General 
Psychiatry, Vol. 48, Issue 1, January 1991, pp. 43-51.
16 F. X. Vollenweider et al., ‘Acute Psychological and Neurophysiological Effects of MDMA in Humans’, Journal of Psychoactive 
Drugs, Vol. 34, Issue 2, 2002, pp. 171-184; G. J. H. Dsumont et al., ‘Acute neuropsychological effects of MDMA and ethanol 
(co-)administration in healthy volunteers’, Psychopharmacology, Vol. 197, Issue 3, April 2008, pp. 465-474; J. H. Halpern et al., 
‘Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure 
to other drugs’, Drug and Alcohol Dependence, Vol. 75, Issue 2, August 2004, pp. 135-147.
17 K. I. Bolla, U. D. McCann, and G. A. Ricaurte, ‘Memory impairment in abstinent MDMA (“Ecstasy”) users’, Neurology, Vol. 51, Issue 
6, December 1998, pp. 1532-1537.
18 National Advisory Committee on Drugs and Public Health Information and Research Branch, Drug use in Ireland and Northern 
Ireland: First results from the 2010/11 Drug Prevalence Survey, Dublin, 2011, p. 13. 
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and lack of concentration and motivation. In young people, long-term use can impact on brain function and 
behaviour and is associated with schizophrenia. The use of cannabis has been associated in a number of studies 
with the use of other illicit drugs, and it may provide a gateway, therefore, into habitual consumption of other 
substances19. At the same time cannabinoids from the marijuana plant may be useful in reducing pain and 
inflammation, muscle control, controlling epileptic seizures, and is used in the treatment of multiple sclerosis.  
There is a need to establish an expert committee to examine these issues. 
Use of all of these drugs, to a greater or lesser degree, bears the possibility of developing substance use 
disorders or dependency, which carry social and psychological consequences independent of the physiological 
effects caused by the ingestion of each of these chemicals. The patterns and locations of use, dosages and 
physiological effects all differ significantly between these classes. As a result, in order to achieve success in 
preventing and combating drug use, all public policy in this area must be reflective of these variances.
Hospitalisation and Mortality amongst Drug Users in Ireland
Recently released statistics from the Health Research Board on drug-related deaths in Ireland show that in the 
eight year period from 2004 to 2011, a total of 4,606 deaths by drug poisoning and deaths amongst drug users 
were recorded, with the annual number of poisoning deaths recorded in 2011 rising to 365, compared to the 
267 recorded in 2004.20 The majority of these deaths involved a number of substances simultaneously, including 
alcohol, however alcohol alone was responsible for only 17%, or sixty-one, of deaths due to poisoning in 2011, 
while just under 25% were caused by a single non-alcohol drug.21 The disastrous consequences of opioid use 
are evident from this report, as drugs of this class were shown to be involved in 57% of poisoning fatalities.22 
Ireland has the third-highest rate of adult drug-induced deaths in the EEA, with 70.5 cases per million presenting 
annually, behind only Estonia (190.8 cases per million), and Norway (75.9 cases per million).23 Adult drug-induced 
deaths in Ireland occur at more than three times the EU average of 17.1 cases per million, and more than twice 
the west European average of 29.1 cases per million.24 78% of those who die from poisoning as a result of opioid 
use are not part of a methadone treatment programme, underscoring how vital treatment access is to users.25
In 2011 there were 580 overdose cases admitted to Irish hospitals that involved narcotics or hallucinogens 
including opioids, cocaine, and cannabis, with a further 960 resulting from benzodiazepine ingestion.26 
Furthermore, those with drug disorders represented 18% of all admissions to Irish psychiatric units and hospitals 
in 2013, a figure that amounts to over 3,300 cases.27  
19 D. M. Fergusson, J. M. Boden, and L. J. Horwood, ‘Cannabis use and other illicit drug use: testing the cannabis gateway 
hypothesis’, Addiction, Vol. 101, Issue 4, pp. 556-569; H. O. Mellberg, A. M. Jones, and A. L. Bretteville-Jensen, ‘Is cannabis a 
gateway to hard drugs?’, Empirical Economics, Vol. 38, Issue 3, pp. 583-603.
20 Health Research Board and Public Health Information and Research Branch, Drug-Related Deaths and Deaths among Drug Users 
in Ireland: 2011 figures from the National Drug-Related Deaths Index, January 2014, p. 1.
21 Ibid, p. 7.
22 Ibid, p. 8.
23 European Monitoring Centre for Drugs and Drug Addiction, European Drug Report 2014: Trends and Developments, Publications 
Office of the European Union, Luxembourg, 2014, p. 78.
24 Ibid.
25 C. Ó Súilliobháin, Access to Community Based Drug Treatment, presentation delivered to the British Medical Association and Irish 
Medical Organisation All-Ireland Conference on Mental Health and Addiction, Dublin, 21 November 2014.
26 Health Research Board, 2013 National Report (2012 Data) to the EMCDDA by the Reitox National Focal Point: Ireland – New 
Developments,Trends, and In-Depth Information on Selected Issues, Dublin, 2013, pp. 88-89.
27 Health Research Board, HRB Statistics Series 25: Activities of Irish Psychiatric Units and Hospitals 2013 – Main Findings, Dublin, 
2014, p. 4.
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Dual-Diagnosis: Comorbidity of Psychiatric and Substance Abuse Disorders in Ireland
A variety of studies across Europe have estimated that between a third and half of patients being treated for 
substance abuse have an independent co-occurring psychiatric illness.28 These findings have been replicated in 
studies that have focused on cohorts of Irish patients.29 Psychiatric illnesses found to co-occur with substance 
problems range from anxiety or depressive disorders to ADHD, paranoia, schizophrenia, and other mood or 
personality disorders.30 It is possible that a variety of issues lead to comorbidity as described: drug use may cause 
users to experience the symptoms of a psychiatric illness; drug use may lead to the triggering of an underlying 
psychiatric illness; suffers of psychiatric illnesses may use drugs to alleviate the symptoms of such illnesses; and 
problem substance use and psychiatric illnesses may both be triggered by common factors such us environmental 
stressors or genetic predispositions.31
Research has shown that those suffering from comorbid substance abuse and psychiatric illness typically 
experience poorer treatment outcomes than those suffering from a single mental health ailment. Those suffering 
from a substance misuse disorder are more likely to relapse following treatment and in some cases may take 
longer to recover from a psychiatric episode.32 
Supply and Prevention of Drug Use in Ireland
The current strategy for tackling drug abuse is contained in the National Drugs Strategy (Interim) 2009-2016 
which, as mentioned above, makes a number of recommendations under the pillars of Supply, Prevention, 
Treatment and Rehabilitation, and Research. 
The first objective of the Strategy aims to reduce the volume of illicit drugs in Ireland with a targeted increase of 
25% in the volume of drugs seized. However despite the increase in seizures between 2004 and 2007 Figures 5 
and 6 show the extent to which drug seizures have fallen since their height in 2007. This reduction in seizures, 
coupled with the increase in drug use nationally reported across almost all substances, leads to the conclusion 
that the reduction in seizure numbers are not as a result of a fall in demand. The restriction of availability, 
much like in the case of alcohol, is an important facet in tackling consumption, and therefore the IMO urges 
the Government to restore all resources to State agencies charged with seizing drugs and intercepting drugs 
shipments in an effort to reduce the volume of drugs on Irish streets, thereby affecting their availability and price 
in a manner that will reduce consumption.
Stiff penalties are also required to deter the importation and sale of illegal drugs into Ireland. The IMO 
recommends that mandatory life sentences should be imposed on those found guilty of major drug crimes. 
28 S. J. Schulte et al., ‘Treatment approaches for dual diagnosis clients in England’, Drug and Alcohol Review, Vol. 27, Issue 6, 
November 2008, pp. 650-658; R. Wynn, A. Landheim, and E. Hoxmark, ‘Which factors influence psychiatric diagnosing in 
substance abuse treatment?‘, International Journal of Mental Health Systems, Vol. 7, Issue 1, June 2013, doi: 10.1186/1752-4458-
7-17; K. E. Watkins et al., ‘Prevalence and Characteristics of Clients with Co-Occurring Disorders in Outpatient Substance Abuse 
Treatment’, American Journal of Drug and Alcohol Abuse, Vol. 30, Issue 4, November 2004, pp. 749-764.
29 A. Dixit and A. Payne, ‘Prevalence of substance misuse comorbidity in an Irish university training hospital’, Irish Journal of 
Psychological Medicine, Vol. 28, Issue 4, pp. 201-204; P. D. James, B. P. Smyth, and T. Apantaku-Olajide, ‘Substance use and 
psychiatric disorders in Irish adolescents: a cross-sectional study of patients attending substance abuse treatment service’, Mental 
Health and Substance Abuse, Vol. 6, Issue 2, 2013, pp. 124-132.
30 D. S. Hasin et al., ‘ Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Alcohol Abuse and Dependence in the United 
States’, Archives of General Psychiatry, Vol. 64, Issue 7, July 2007, pp. 830-842.
31 European Monitoring Centre for Drugs and Drug Addiction, Co-morbid substance use and mental disorders in Europe: a review of 
the data, Lisbon, 2013, p. 3, (available at http://www.emcdda.europa.eu/publications/emcdda-papers/co-morbidity [accessed on 4 
March 2015 at 10.23am]). 
32 M. Tohen, C. M. Waternzux, and M. T. Tsuang, ‘Outcome in mania: a 4-year prospective follow-up of 75 patients using survival 
analysis’, Archives of General Psychiatry, Vol. 47, 1990, pp. 1106-1111; M. Tohen et al., ‘The McLean-Harvard First-Episode Mania 
Study: Prediction of Recovery and First Recurrence’, American Journal of Psychiatry, Vol. 160, Issue 12, December 2003, pp. 2099-
2107.
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Figure 5: Trends in the Total Number of Drug Seizures and Cannabis Seizures, 2003-2012
All Seizures
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
6377 5299 6362 8417 10444 9991 5494 5477 6014 5369
3705 2850 3555 4243 5176 5652 2314 2268 3137 2912
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Source: Health Research Board, 2013 National Report (2012 Data) to the EMCDDA by the Reitox National Focal 
Point: Ireland – New Developments, Trends, and In-Depth Information on Selected Issues, Dublin, 2013, p. 147-
148.
Figure 6: Trends in the Number of Seizures of Selected Drugs, Excluding Cannabis, 2003-2012
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Point: Ireland – New Developments, Trends, and In-Depth Information on Selected Issues, Dublin, 2013, p. 147-
148.
Given the clear and well accepted health risks associated with drug use, much psychological and sociological 
research has attempted to understand the reasons for persistent drug use in populations and many competing 
theories exist to explain the phenomenon. Common themes, however, are evident across the academic literature 
in this field, which can essentially be distilled to socio-economic class or standing, peer use, level or standard 
of parental or guardian supervision, and drug market forces, namely availability and cost. A recent study by the 
NACDA reaffirms that many of these aforementioned themes play primary causal roles in drug use in Ireland, with 
the absence of facilities for young people; high unemployment; boredom; poor parental supervision; and drug 
availability mentioned as part of the study.33 
33 J. Connolly and M. Donovan, Illicit Drugs Markets in Ireland, National Advisory Committee on Drugs and Alcohol, Dublin, 2014, 
pp. 1-10. 
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In 2013, the Department of Children and Youth Affairs provided overall funding of €51.423m to support the 
provision of youth services, with an additional €1.55m in capital funding for a Youth Café Scheme in that year.34 
While the additional funding is welcome, further resources are required to support evidence-based training, and 
education and prevention programmes. Established organisations with high levels of respect in the community, 
such as sporting bodies, theatre and artistic groups, and social clubs or societies focused young people or young 
adults must be encouraged to promote drug education and prevention programmes in a manner where adequate 
support, both in terms of training and finance, is provided to local leaders of such groups or projects. This also 
must be completed in a manner that attempts to guarantee the availability of such services to young people and 
young adults nationally. 
IMO Recommendations
• Restore funding and resources to State agencies in order to halt and reverse the sharp reduction in 
drugs seizures of recent years.
• Impose mandatory life sentences for all those convicted of major drug trafficking crimes. 
• Strengthen funding and resources to support community organisations focused on young people or 
young adults that promote drug education and prevention programmes. 
Gambling Addiction in Ireland
Though often overlooked, most likely due to its insidious and mental effects on health, rather than the severe and 
acute physiological reactions that can be produced by alcohol and drug abuse, problem gambling is undoubtedly 
a strong feature on the Irish addiction landscape. In recent times well-known Irish and Northern Irish athletes and 
sports figures such as Niall McNamee, Oisín McConville, and Keith Gillespie have spoken publicly about their 
struggles with gambling addiction. No academic studies have adequately investigated the extent of problem 
gambling in Ireland, however what research has been conducted indicates that at any one time 1% of the adult 
population may be experiencing problem gambling, while lifetime prevalence of this addiction may be as high as 
5%.35 Without a detailed awareness of the extent and causes of this problem, the potential for the development 
of effective remedial action is greatly reduced. The IMO therefore calls for urgent critical survey work to be 
conducted into problem gambling on this island, which will aid policy makers and health service providers in 
tackling this condition.
Although it is unclear, as a result of the absence of adequate research, what the precise gambling habits of the 
Irish populace are, it is evident that gambling is a growing sector in Ireland. Expenditure in gambling grew from 
€1.6bn in 2001 to €3.6bn in 2006, with share prices of companies associated with gambling services continuing 
to rise, demonstrating confidence in the industry.36 As many as 60% of Irish adults gamble to some degree 
weekly, although for some the extent of this gambling may be playing the National Lottery.37 There is little reliable 
information however on betting patterns outside of the National Lottery, or on the average weekly expenditure of 
Irish gamblers on the habit. 
Supply and Prevention Measures
Robust regulations capable of protecting young people from the advertising efforts of gambling or betting 
service providers, or the means through which such operators attempt to win customers, do not yet exist. The 
IMO believes that regulatory controls to limit the exposure of young people to gambling should be instigated 
immediately, including those that limit the intensity or frequency of gambling service advertisements, especially 
those hosted on web pages and social networks that facilitate immediate access to online gambling through 
“one-click” hyperlinks. 
34 Department of Health, National Drugs Strategy 2009-2016: Progress Report to End 2013, Dublin, 2014, p. 13.
35 Institute of Public Health in Ireland, Developing a Population Approach to Gambling: Health Issues – Briefing Paper, Dublin, 
December 2010, p.1 (available at http://www.publichealth.ie/files/file/Developing%20a%20population%20approach%20to%20
gambling.pdf [accessed on 10 March 2015 at 4.22pm]); C. O’Gara, ‘Assessing and treating problem gambling’, Irish Medical 
Times, Dublin, 5 October 2010, (available at http://www.imt.ie/clinical/2010/10/assessing-and-treating-problem-gambling.html 
[accessed on 11 March at 9.41am]).
36 P. Wall, Gambling in Ireland: Some public health considerations, Paper presented at the Public Health Conference, University 
College Dublin, Dublin, 2007 p. 1; Institute of Public Health in Ireland, Developing a Population Approach to Gambling: Health 
Issues – Briefing Paper, Dublin, December 2010, p. 2, (available at  [accessed on 10 March 2015 at 4.22pm]).
37 M. D. Griffiths, ‘Problem gambling in Europe: what do we know?’, Casino and Gaming International, Vol. 6, Issue 2, 2010, pp. 81-
84.
14
IMO Position Paper - Addiction and Dependency
Taking a tough regulatory line is essential. It has been well established that gambling service providers rely on 
problem gamblers for a considerable fraction of their income, with estimates from studies in Australia and Canada 
revealing this amounted to one-third and one-quarter of income in the respective cases.38 There is therefore little 
incentive for the industry to self-regulate effectively or put in place strong measures that will drastically reduce the 
prevalence of problem gambling.
Effective educational programmes are also required to raise awareness of problem gambling. Social, Personal, and 
Health Education curricula at primary and secondary level deal with a broad variety of addiction and dependence 
topics, but focus heavily on alcohol and drug abuse. Given the prevalence of gambling in Ireland, and the 
increased access that most young people and adults have to gambling through smartphones or other portable 
internet-enabled devices, it is crucial that formal educational programmes are put in place in an effort to prevent 
engagement in problem gambling or behaviour that may lead to problem gambling.
IMO Recommendations 
• Fund research into the extent of problem gambling and its effects on individuals and their families in 
Ireland.
• Introduce regulatory control measures that limit the frequency of advertisements for gambling services.
• Develop educational programmes that raise awareness of the issue of problem gambling in the Social, 
Personal, and Health Education curricula.
Substance Abuse and Addiction Services in Ireland
Detoxification and rehabilitation services for alcohol and drug dependency are provided by a mixture of public, 
voluntary not-for-profit, and private services, including general hospitals and psychiatric hospitals. Most treatment 
takes place in outpatient facilities, with more complex treatment taking place in residential settings. No centralised 
strategy exists for the treatment of substance abuse in Ireland, and significant gaps in services exist. 
• Despite the substantial prevalence of alcohol dependence amongst adults in Ireland, relatively few are 
treated. Problem alcohol use was treated in 8,336 cases in 2012 in Ireland and the prevalence of problem 
alcohol treatment in the age fifteen to sixty-four group was 0.26%, with a median treatment age of forty.39 
The WHO’s assessment of the prevalence of alcohol dependence in Europe measures Ireland at 3.8% of the 
adult population, while other estimates suggest that approximately 7% may be dependent.40 This clearly 
displays that health services in Ireland have failed to penetrate the sizeable portion of the Irish population who 
are alcohol dependent, particularly within young adult age groups, to any great degree. This failure to treat 
alcohol dependence leads to continuing pressure on health services in other areas and increased premature 
mortality. 
 There is a clear disparity in the uptake of treatment services for problem alcohol use nationally, with treatment 
incidence ranging from 60.3 per 100,000 of the age fifteen to sixty-four population in Clare, to 309.6 per 
100,000 of the age fifteen to sixty-four population in Waterford, as displayed in Figure 7. Furthermore, the 
incidence of treatment does not appear to bear any correlation with alcohol consumption in the assessed 
regions, as previous observations have reported both Clare and Dublin as amongst the top five counties in 
Ireland in terms of alcohol consumption, yet have some of the lowest rates of treatment.41 This is suggestive 
that problem alcohol treatment in Ireland is not responsive to the level of alcohol abuse or dependence in 
various regions of the country, but instead is dependent on criteria other than patient need.
38 R. J. Williams, and R. T. Wood, ‘The Proportion of Gaming Revenue Derived from Problem Gamblers: Examining the Issues in a 
Canadian Context’, Analyses of Social Issues and Public Policy, Vol. 4, Issue 1, pp. 33-45; The Productivity Commission, Australia’s 
Gambling Industries, Report No. 10, AusInfo, Canberra, 1999, p. 21.
39 Health Research Board, Treated alcohol use in Ireland: figures for 2012 from the National Drug Treatment Reporting System, 
National Health Information Systems, Dublin, 2014, p. 1, (available at [accessed on 22 January 2015 at 12.30pm]).
40 World Health Organisation, Global Status Report on Alcohol and Health 2014, Geneva, 2014, p. 216; National Advisory Committee 
on Drugs and Alcohol and Public Health Information and Research Branch, Drug Use in Ireland and Northern Ireland: Alcohol 
Consumption and Alcohol-Related Harm in Ireland 2010/2011 Drug Prevalence Survey, Dublin, 2012, p. 10.
41 L. Delaney, A. Kapteyn, and J. Smith, ‘Why do some Irish drink so much? Family, historical and regional effects on students’ alcohol 
consumption and subjective normative thresholds’, Review of Economics of the Household, Vol. 11, Issue 1, March 2013, pp. 1-27.
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Figure 7: Average Annual Incidence of Treated Problem Alcohol Use by County of Residence, per 100,000 
of the 15-64 Year Old Population
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• From 2003 to 2008 problem benzodiazepine use treated by Irish health services rose by 63%, increasing from 
1,054 cases to 1,719.42 The number of cases where benzodiazepines were the main problem substance was small, 
amounting to just 167 cases in 2008, however the number of cases where benzodiazepines were reported as a 
secondary or additional problem substance was considerably larger, with 982 cases reported in 2003, rising to 1,562 
cases by 2008. There are currently, however, no appropriate acute treatment facilities for those with alcohol and 
benzodiazepine addiction.43
• With some of the highest drug-related death rates and opioid dependence rates in the EU, reductions in the number 
of opioid-related problem drug cases entering treatment, seen between 2011 and 2012, is of particular concern. 
The 9% reduction in cases entering treatment year-on-year (4,351 in 2011 to 3,971 in 2012) shows that, despite 
the increasing prevalence of opioid use, fewer problem users are accessing treatment. Ireland has 8,923 clients in 
substitution treatment for opioid use from a total opioid user population of approximately 21,000 people.44 This 
42 D. Bellerose et al., Problem Benzodiazepine Use in Ireland: Treatment (2003 to 2008) and deaths (1998 to 2007), Health Research Board, 
Dublin, 2010, p. 1-3.
43 Ibid. 
44 European Monitoring Centre for Drugs and Drug Addiction, European Drug Report 2014: Trends and Developments, Publications Office 
of the European Union, Luxembourg, 2014, p. 73; J. Long and S. Lyons, ‘Problem opiate use in Ireland’ in Drugnet Ireland, Issue 32, Winter 
2009, pp. 11-14.
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compares unfavourably to many other west European states including Luxembourg, Malta, Italy, Austria, the 
United Kingdom, and the Netherlands, all of which report that the majority of problem opioid users within 
their states are receiving substitution treatment.45
 The Methadone Protocol Scheme was introduced in 1998 following a shift in policy direction regarding drug 
treatment from an in-patient abstinence philosophy to a community-based model of services delivered by 
GPs from a harm reduction perspective. At the IMO and BMA Northern Ireland Joint Conference on Mental 
Health and Addiction in November 2014, a number of issues were raised in relation to the Scheme. 
 While the majority of opioid users are based in Dublin, approximately 30% live outside the capital.46 Despite 
this, the distribution of methadone treatment services remains concentrated in Dublin, with few Level 2 GPs 
practising outside the Dublin region and none west of the Shannon. In 2009 8,551 patients were receiving 
methadone treatment,  however only 1,674 of these were patients of a Level 2 GP.47 Figure 8 clearly shows 
this unequal distribution, which severely limits the treatment options of those living outside of the Dublin 
area. 
Figure 8: Geographical Distribution of Level 2 GPs in Ireland
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45 Ibid, p. 59.
46 A. Kelly, C. Teljeur, M. Carvalho, Prevalence of Opiate Use in Ireland 2006: A 3-Source Capture Recapture Study, National Advisory 
Committee on Drugs and Alcohol, Dublin, 2009, p. 7. 
47 M. Farrell and J. Barry, The Introduction of the Opioid Treatment Protocol, Health Service Executive Social Inclusion Unit, Dublin, 
2010, p. 7.
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 Other issues highlighted at the IMO and BMA Northern Ireland All-Ireland Conference on Mental Health 
and Addiction were the lack of governance structures for addiction services, the absence of evidence-
based guidelines for care, and a focus on the medical model rather than a more holistic approach including 
psychotherapeutic interventions for the treatment of patients. 
 In 2009 the HSE commissioned Professor Michael Farrell to carry out a review of the Methadone Treatment 
Protocol (MTP). The report published in 2010 made a number of proposals including recommendations 
in relation to maximising treatment provision and the effectiveness of referral pathways as well as 
recommendations in relation to the enrolment and training of GPs in the MTP. The IMO supports the 
recommendations of the Farrell Report (2010) and calls on the HSE to allow for the expansion of numbers 
of patients on the Opioid Treatment Protocol and thus increase access to treatment for heroin dependence 
throughout the country.
• Certain harm reduction initiatives such as the Pharmacy Needle Exchange have been successful in reducing 
the spread of blood-borne diseases and directing patients towards treatment services.48 Given Ireland’s 
high rate of adult drug-induced deaths, it would be prudent for research to be conducted that will assess 
the potential benefits and risks of establishing medically-supervised safer injection facilities within State as 
a means of curtailing deaths due to overdose and directing further patients into treatment. Several other 
EU states, such as Portugal, Germany, and Spain have introduced such sites, which concentrate on harm 
reduction and prioritising the health interests of the drug user. International research has established the 
ability of such facilities to reduce drug-related harm to users, and so this option must be properly assessed as 
a potential viable public health measure to tackle drug-related harm.49
• A Vision for Change recommended the development of specialist services for patients with dual-diagnosis, 
comorbid substance abuse and mental illness, with clear pathways of referral in and out of services. Bar 
a dual diagnosis clinic at the National Drug Treatment Centre, few developments have been made in 
the establishment of services for patients with comorbid substance abuse and mental illness, or in the 
development of agreed protocols in the management of patients with co-existing disorders. The majority 
of patients continue to be treated by the mental health services or addiction services depending on their 
primary diagnosis. Research has indicated that addiction services in Ireland are reluctant to admit and treat 
patients with comorbid disorders due to a lack of mental health training of staff in those facilities.50
• In addition, there is no statutory provision of services to treat gambling addiction in Ireland. Financial loss and 
debt are often a consequence of problem gambling and as such private services are generally prohibitive to 
patients with a gambling addiction. 
IMO Recommendations
The IMO is calling on the Government to urgently create a strategy for the development of treatment and 
rehabilitation services for alcohol and drug dependency to include the:
• establishment of acute alcohol and illicit drugs detoxification centres for those who wish to choose 
detoxification as part of their recovery; 
• development of appropriate acute treatment facilities for those with alcohol and benzodiazepine 
dependency;
• full implementation of the Farrell Report (2010) to allow for the expansion of numbers of patients 
on the Opioid Treatment Protocol and thus increase access to treatment for heroin dependence 
throughout the country;
• pursuit of research that will assess the potential benefits and risks of utilising supervised injection 
sites as a means of reducing drug-related harm and bringing patients into contact with drug treatment 
services;
48 Health Service Executive Health Protection Surveillance Centre, Health Protection Surveillance Centre Annual Report 2012, Dublin, 
2013, pp. 89-97; Department of An Taoiseach, Programme for Government Annual Report 2015, Dublin, 2015, p. 70; J. Long, J. 
Doyle, and D. O’Driscoll, ‘Pharmacy needle exchange in Ireland’, Drugnet Ireland, Issue 49, Spring 2014, pp. 19-20.
49 M. S. Milloy et al., ‘Estimated Drug Overdose Deaths Averted by North America’s First Medically-Supervised Safer Injection 
Facility’, PLoS ONE, 3(10), October 2008: e3351. doi:10.1371/journal.pone.0003351. 
50 H. Byrne, The role of mental health service (psychiatrists) and primary care services (GPs) in their treatment of dual diagnosis, a 
comparative study, Thesis (Master’s), Dublin City University, 2006, pp. 50-51.
18
IMO Position Paper - Addiction and Dependency
• development of specialist services in dual-diagnosis, comorbid substance dependency, and mental 
health illness with appropriate pathways of referral in and out of services and standardised protocols 
for care;
• appropriate training of all physicians in treatment of addiction and dual-diagnosis both as part of the 
core curriculum and continuing professional development; and
• provision of State funding for the treatment of gambling addiction.
The Social Cost of Addiction
Addiction and Crime
The link between addiction and crime has been well established and extends beyond the simple illegality of 
manufacture, possession, or trade of most psychoactive substances in Ireland. This link is drawn primarily as a 
result of the economic incentives to commit crimes as a means of financing habitual drug use or dependency. 
A 2004 study, conducted by An Garda Síochána, concluded that 28% of all detected crime was perpetuated by 
drug users, while virtually all of the opioid users surveyed as part of this study admitted to funding their drug 
habits, at least in part, through criminal activities.51
Additionally, an internationally recognised connection exists between alcohol consumption and violent crimes. 
Statistics collected by An Garda Síochána support such findings, and an assessment of recorded public order 
incidents sampled over a five-month period showed that alcohol had been consumed by the offender in 97% of 
cases.52
One of the central features absent from Irish alcohol health services is an effective intervention programme, 
incorporating a referral procedure, for people who have come to the attention of various State authorities such 
as An Garda Síochána or officers of the Department of Social Protection. Systemised intervention schemes of this 
kind have been advocated repeatedly and a strong evidence base exists to suggest their efficacy.53 Despite such 
recommendations, a comprehensive system has not been implemented whereby alcohol dependence risk-factors, 
such as alcohol abuse, identified by State agencies do not provoke an intervention by health service providers. 
In order to reduce crime, factors that encourage or motivate criminal activities must be tackled. By effectively 
treating drug use, the impact of the criminal associations of addiction and dependency can be mitigated, thus 
rendering the policing of communities with an existing drugs problem more manageable.
It is also crucial that former drug users, including those who have been convicted of minor possession charges, 
are effectively supported in their reintegration into the workforce. Integration or reintegration into the workforce 
has been shown to be one of the most effective measures in preventing relapses into drug use, particularly 
amongst those who have served time in prison for drug possession or use.54 Educational and vocational 
programmes that increase a treated problem drug user’s labour market attractiveness must be seen as a vital 
component in a holistic treatment plan, as it is often only through the reintegration of the individual into society 
that reuse can be avoided. It must also be acknowledged that Ireland is the only country within the EU to 
not have in place a form of spent convictions legislation that will allow minor crimes to be removed from an 
individual’s criminal record and that the implementation of such legislation would better enable many to re-enter 
the workforce following a conviction.
51 M. Furey and C. Browne, Opiate use and related criminal activity in Ireland 2000 & 2001: research report no. 4/03, An Garda 
Síochána, Templemore, 2004.
52 University College Dublin Institute of Criminology, Public order offences in Ireland: a report by the Institute of Criminology, Faculty 
of Law, University College Dublin for the National Crime Council, Stationery Office, Dublin, 2003, p. 79.
53 Department of Health, Steering Group Report on a National Substance Misuse Strategy, Stationery Office, Dublin, 2012, p. 61; J. 
Barry and R. Armstrong, Towards a Framework for Implementing Alcohol Based Alcohol Interventions, Health Service Executive, 
Dublin, 2011, pp. 1-24; T. H. Bien, W. R. Miller, and J. S. Tonigan, ‘Brief interventions for alcohol problems’, Addiction, Vol. 88, 
Issue 3, 1993, pp. 315-336; A. I. Wilk, N. M. Jensen, and T. C. Havighurst, ‘Meta-analysis of randomized control trials addressing 
brief interventions in heavy alcohol drinkers’, Journal of General Internal Medicine, Vol. 12, 1997, pp. 74-83. 
54 Freudenberg, N. et al., ‘Coming Home From Jail: The Social and Health Consequences of Community Reentry for Women, Male 
Adolescents, and Their Families and Communities’ in the American Journal of Public Health, Vol. 95, Issue 10, October 2005, pp. 
1725-1736.
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Addiction and Homelessness
At the time of the last census, in April 2011, it was estimated that approximately 3,800 people in Ireland were 
homeless.55 The homeless population has been observed to have a higher prevalence of substance abuse 
and dependency than the general population, particularly of illicit drugs. 36% of Irish homeless people are 
problematic drug users, with 22% of the homeless population being current users of heroin.56 This very much 
contrasts to the equivalent figure in the general population, where 0.7% of adults are estimated to be heroin 
users.57
Alcohol and drug use is also a major causal factor leading to poverty and homelessness. Personal drug use (19% 
of homeless people) and alcohol use (13% of homeless people) were rated as the second and third most common 
causes of homelessness respectively in an analysis conducted by the National Advisory Committee on Drugs and 
Alcohol, after family conflict (24% of homeless people).58 Homelessness is also an impediment to recovery with 
many of the most vulnerable homeless patients relapsing into addiction after detoxification. 
Hidden Harm
The concept of ‘Hidden Harm’, that is to say the effect of addiction on persons other than the addict, such as 
close friends, family, or dependents, has received some academic attention in recent years. International research 
has shown that children, in particular, suffer acutely from a parent’s hazardous relationship with alcohol, causing 
emotional distress, and being the genesis for physical and verbal abuse, as well as a degradation in expected 
parental care and support.59 A large study into alcohol’s harmful effects on others in Australia revealed that 12% of 
parents and carers reported that one or more of their children, under eighteen years of age, had been physically 
hurt, emotionally abused, or exposed to domestic violence because of the drinking of others, while a similar 
examination in the UK concluded that up to one in eleven children are affected by parental alcohol problems.60 
Irish children are affected to the same degree as their international comparators, a fact confirmed by research 
conducted by the Irish Society for the Prevention of Cruelty to Children (ISPCC), which reported that 9% of 
children, aged between twelve and eighteen years of age, said that the alcohol use of their parents had affected 
them in a negative way.61 Indeed, hazardous alcohol use in the presence of children is common in Ireland, with 
over half of all Irish adults (56%) who have children living in their households reporting regular hazardous drinking 
habits.62 Children’s exposure to parental drinking can have both immediate and persistent effects, both in terms 
of their attitude to alcohol, and their psychological health. Children who see their parents drunk are twice as likely 
to regularly get drunk themselves, while the effects of parental problem drinking have been noted to manifest 
as a broad range of psychological disorders in children such as shyness and social withdrawal, anti-social and 
aggressive conduct, and poor academic performance.63 The consequences of such psychological disorders are 
obvious and may impact the development and prospects of children exposed to parental problem alcohol use.
55 Central Statistics Office, Homeless Persons in Ireland: A special Census report, Cork, 2011, p. 1, (available at   [accessed on 15 
January at 11.42am]). 
56 M. Lawless, and C. Corr, Drug Use Among the Homeless Population in Ireland: A Report for the National Advisory Committee on 
Drugs, Stationery Office, Dublin, 2005, p. 97.
57 J. Long and S. Lyons, ‘Problem opiate use in Ireland’ in Drugnet Ireland, Issue 32, Winter 2009, pp. 11-14.
58 M. Lawless and C. Corr, Drug Use Among the Homeless Population in Ireland: A Report for the National Advisory Committee on 
Drugs, Stationery Office, Dublin, 2005, p. 54-57.
59 A. Wales and E. Gillan, Untold Damage: children’s accounts of living with harmful parental drinking, Scottish Health Action on 
Alcohol Problems (SHAAP) and ChildLine in Scotland, Edinburgh, 2009, p. 9.
60  A. M. Laslett et al., The Range and Magnitude of Alcohol’s Harm to Others, Fitzroy, AER Centre for Alcohol Policy Research, 
Turning Point Alcohol and Drug Centre, Eastern Health, Victoria, 2010, p. 108; Prime Minister’s Strategy Unit, Alcohol Harm 
Reduction Strategy for England, Cabinet Office Strategy Unit, London, 2004, p. 13.
61 Irish Society for the Prevention of Cruelty to Children, If They’re Getting Loaded, Why Can’t I?, Dublin, 2010, p. 9.
62 P. Bremner et al., Young People, Alcohol and Influences: A study of young people and their relationship with alcohol, Joseph 
Rowantree Foundation, London, 2011, pp. 28-29.
63 S. Butler ‘Addiction problems, addiction services, and social work in the Republic of Ireland’, Journal of Social Work Practice in the 
Addictions, Volume 2, 2002, pp. 31-48.
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Similar problems can be demonstrated in families where parental problem narcotic drug use is experienced. 
Parental problem drug use often impedes parenting and prevents the development of a suitably nurturing 
environment in which to raise children.64 Furthermore, the risk of physical and sexual abuse of children more than 
doubles in households where a parent exhibits a substance abuse problem.65 
Drugs Task Forces
The Local and Regional Drugs Task Forces, which have been in operation for almost twenty years, also have a 
crucial role to play in reducing drug consumption at regional and local level. The role of the Drugs Task Forces 
is to assess the nature and extent of drug problems in their area and develop local and regional strategies and 
action plans, and to co-ordinate local services to provide targeted responses at local level. Services include 
residential and community-based drug treatment and rehabilitation services, counselling, youth drug prevention 
projects, family support services and other measures aimed at reducing local substance abuse. 
Now operating under the auspices of a newly formed National Co-ordinating Committee for Drug and Alcohol 
Task Forces, these bodies will have responsibility for alcohol use, as well as drugs. These changes arise from 
the Department of Health’s Report on the Review of the Drugs Task Forces and the National Structures under 
which they operate, which was published in December 2012. The Department has not yet produced a clear 
and comprehensive report on the timeframe by which all of the fifteen recommendations contained in the 
report should be completed, including the amalgamation and expansion of a number of task forces nationwide, 
reducing their overall number from twenty-four to nineteen.66
Regrettably the ability of these task forces to achieve meaningful results in the combat of substance abuse in 
Ireland has been effectively neutered by continuous budget cuts. From 2013 to 2014 the funding from the Drugs 
Initiative, provided to Local and Regional Drugs Task Forces to spearhead community-based initiatives was 
reduced by 7%, from €29.95m to €27.95m.67 There is no planned increase in these funds this year, which will 
now be split between available monies from the Department of Health (€7.83m) and the HSE (€21.6m).68 This is 
in addition to a succession of cuts to the funding afforded to these bodies over the past seven years, with some 
budget cuts to task forces reported to be in excess of 20% over this period.69 
Ultimately, if these renamed task forces are to play an active and pivotal role in reducing the supply of and 
demand for drugs at local and regional level throughout Ireland, they must be adequately resourced and given 
the ability to apply for funding for community-based projects through a system that is clear, simple, transparent, 
and comprehendible to all involved in the task forces’ activities.
IMO Recommendations
• Introduce spent convictions legislation that will allow minor crimes to be removed from an individual’s 
criminal record, to better enable those convicted of minor possession offences to re-enter the 
workforce.
• Develop an effective substance abuse and dependence intervention programme, incorporating a 
referral procedure, for people who have come to the attention of various State authorities, such as An 
Garda Síochána or officers of the Department of Social Protection.
• Establish a cross departmental integrated approach to treatment and rehabilitation to ensure the 
education, housing, and social protection needs of patients and their families are met.
• Provide financial support to Local and Regional Drugs Task Forces and social services to address child 
and family related drug problems.
64 M. Bernard and N. McKenganey, ‘The impact of parental problem drug use on children: what is the problem and what can be done 
to help?’, Addiction, Volume 99, Issue 5, May 2004, pp. 552-559.
65 C. Walsh, H. L. MacMillan, and E. Jamieson, ‘The relationship between parental substance abuse and child maltreatment: findings 
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Funding
Where reductions in available funding have given rise to impediments to effective treatment, alternative revenue 
streams should be sought. Proceeds acquired by the Criminal Assets Bureau relating to drug crime should be 
reinvested in drug treatment programs. In much the same way, levies should be placed on the alcohol and 
gambling industries in Ireland to ensure that contributions from these sectors of the economy fund the treatment 
and rehabilitation of those who have developed clinical dependencies on their products. 
Mounting a successful campaign against drug use in Ireland requires, not only multi-faceted responses from our 
community infrastructure, education, health, housing, and criminal justice systems, but also adequate resources, 
both human and financial, to meet the challenge. So far, Ireland has failed to devote the necessary attention and 
resources to this problem to realise the possibility of reversing current usage trends.
IMO Recommendations
• Introduce a levy on the alcohol and gambling industries to fund the treatment and rehabilitation of 
those who have developed clinical dependencies on their products.
• Route proceeds acquired by the Criminal Assets Bureau relating to drug crime to investment in drug 
treatment programs.
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Summary of Recommendations
Supply and Prevention
Alcohol
• Implement the National Alcohol Strategy without delay to take immediate action to ban sponsorship 
and promotion of sports by the alcohol industry, and to introduce Minimum Unit Pricing for alcohol 
products.
Substance Abuse
• Restore funding and resources to State agencies in order to halt and reverse the sharp reduction in 
drugs seizures of recent years.
• Impose mandatory life sentences for all those convicted of major drug trafficking crimes. 
• Strengthen funding and resources to support community organisations focused on young people or 
young adults that promote drug education and prevention programmes.
Gambling
• Fund research into the extent of problem gambling and its effects on individuals and their families in 
Ireland.
• Introduce regulatory control measures that limit the frequency of advertisements for gambling 
services.
• Develop educational programmes that raise awareness of the issue of problem gambling in the Social, 
Personal, and Health Education curricula.
Substance Abuse and Addiction Services
The IMO is calling on the Government to urgently create a strategy for the development of treatment and 
rehabilitation services for alcohol and drug dependency to include the:
• establishment of acute alcohol and illicit drugs detoxification centres for those who wish to choose 
detoxification as part of their recovery; 
• development of appropriate acute treatment facilities for those with alcohol and benzodiazepine 
dependency;
• full implementation of the Farrell Report (2010) to allow for the expansion of numbers of patients 
on the Opioid Treatment Protocol and thus increase access to treatment for heroin dependence 
throughout the country;
• pursuit of research that will assess the potential benefits and risks of utilising supervised injection 
sites as a means of reducing drug-related harm and bringing patients into contact with drug treatment 
services;
• development of specialist services in dual-diagnosis, comorbid substance dependency and mental 
health illness, with appropriate pathways of referral in and out of services and standardised protocols 
for care;
• appropriate training of all physicians in treatment of addiction and dual-diagnosis both as part of the 
core curriculum and continuing professional development; and
• provision of State funding for the treatment of gambling addiction.
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Reducing the Social Cost of Addiction
• Introduce spent convictions legislation that will allow minor crimes to be removed from an individual’s 
criminal record, to better enable those convicted of minor possession offences to re-enter the 
workforce.
• Develop an effective substance abuse and dependence intervention programme, incorporating a 
referral procedure, for people who have come to the attention of various State authorities, such as An 
Garda Síochána or officers of the Department of Social Protection.
• Establish a cross departmental integrated approach to treatment and rehabilitation to ensure the 
education, housing, and social protection needs of patients and their families are met.
• Provide financial support to Local and Regional Drugs Task Forces and social services to address child 
and family related drug problems.
Funding Prevention and Treatment
• Ensure that contributions from the alcohol and gambling industries fund the treatment and 
rehabilitation of those who have developed clinical dependencies on their products.
• Route proceeds acquired by the Criminal Assets Bureau relating to drug crime to investment in drug 
treatment programs.
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